In addition, a 65% knockdown of ZEB2 in the luciferase-positive human immature-like T-ALL cell line LOUCY resulted in decreased tumour formation when transplanted into NOD/SCID/Il2Rγ null recipients (Fig. 4c and Supplementary Fig. 9a,b). This evidence concerns the gene ZEB2 and acute lymphoblastic leukemia.